Announced
Completed
Financials
Sources
Tags
digital biomarkers
Friendly
United States
Completed
wearables
Domestic
Private Equity
Acquisition
Minority
Medical Equipment
Private
Biotechnology
Single Bidder
drug development
Synopsis
AyurMaya, an affiliated fund of Matrix Capital Management, led a $45m Series C funding round in Koneksa, a digital biomarkers maker, with participation from Takeda Ventures, Velosity Capital. McKesson Ventures, Merck Global Health Innovation Fund, Novartis (dRx Capital), Spring Mountain Capital and Waterline Ventures. “We contribute to better lives by building health measurements that matter. I’m delighted to welcome John Wagner, one of our earliest collaborators and an industry pioneer to our leadership team. We look forward to accelerating development of our biomarker technology platform and expanding our team to deliver more efficient clinical trials," Chris Benko, Koneksa CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.